King & Wood Mallesons

Firm overview:

King & Wood Mallesons, with “Red Circle Chinese” firm King & Wood and “Big Six” Australian firm Mallesons Stephens Jaques among its legacy firms, is a full service international firm with 26 offices and more than 3,000 legal professionals across Australia, China, Hong Kong, Japan, Singapore and the United States.

The China patent team forms part of the firm’s international intellectual property offering.

The team advises multinational and national companies on IP issues from selecting, protecting and managing patents to developing patent assets. The team’s services include patent re-examination and invalidation and patent validity and patent infringement.

Team overview:

With over 400 patents attorneys, patents agents and patents engineers, KWM covers all the major technical fields. These include telecommunications, computer science, semiconductor, internet technology, electronics and power, pharmaceuticals, medical devices, biotechnology, chemicals, materials, automobiles, mechanicals and design.

Hall of Fame lawyer and co-head of Patents, Tai Hong (Tina) has 28 years’ experience as an IP practitioner, and is a well-known individuals in IP law in the pharmaceutical and healthcare sectors, and has represented clients in many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer in patent invalidation and infringement litigations. She is the counselor-at-law of biopharma Intellectual Property think tank INTERPAT and RDPAC, a R&D pharmaceutical association committee.

Clients:

Pfizer, AstraZeneca, Bayer, Roche/Chugai, Novartis, Novo Nordisk